Insider · CIK 0001166288
Robert E. Hoffman
directorcfoofficer
Files at CYDY (CytoDyn Inc.), ESPR (Esperion Therapeutics, Inc.), HURA (TuHURA Biosciences, Inc./NV), FBLG (FibroBiologics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 12, 2025 |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +5,280 | $0.00 | $0 | 5,280 | Jun 2, 2025 |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,040 | $0.00 | $0 | 7,040 | Jun 2, 2025 |
| May 15, 2025 | CYDY CytoDyn Inc. | AGrant or award Non-qualified stock option (right to buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | May 22, 2025 |
| Apr 1, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Apr 2, 2025 |
| Jan 2, 2025 | HURA TuHURA Biosciences, Inc./NV | AGrant or award Options (Right to Buy)derivative | +51,275 | $0.00 | $0 | 51,275 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.